<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Q&amp;A med Genmab d. 23. marts 2021 - Transcript]]></title><description><![CDATA[<p dir="auto">Session med CEO, Prof. Jan Van de Winkel, Q4 Genmab</p>
<p dir="auto"><a href="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Genmab%202021-03-23.pdf" rel="nofollow ugc">https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Genmab 2021-03-23.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/442512/qa-med-genmab-d-23-marts-2021-transcript</link><generator>RSS for Node</generator><lastBuildDate>Tue, 07 Jul 2026 13:54:51 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/442512.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 24 Mar 2021 09:36:01 GMT</pubDate><ttl>60</ttl></channel></rss>